ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Cognitive impairment in hereditary spastic paraparesis: An overlooked aspect of a motor disorder.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHereditary spastic paraparesis (HSP) are a group of disabling neurological disorders classically defined by progressive spasticity and weakness at lower limbs. Non-motor symptoms may be part of the clinical phenotype. Our aim was to evaluate cognitive abilities, especially executive functions and verbal memory, in different forms of HSP. MATERIAL AND
methodsThis study included 40 patients and 25 matched healthy controls (HC). Among the patients, 18 had SPG4, 6 SPG7, 2 SPG5, 3 SPG11, 3 SPG10, 3 SPG28, and one each had SPG3A, SPG9, SPG15, SPG17 and SPG21. Disease severity was assessed using the Spastic Paraplegia Rating Scale (SPRS). To evaluate cognitive domains, a defined neuropsychological battery was used. Statistical methods included Shapiro-Wilk testing to determine distribution, followed by t-tests, Mann-Whitney U, ANOVA, or Kruskal-Wallis tests as appropriate, with false discovery rate (FDR) correction. Effect sizes were calculated using Cohen's d, rank-biserial correlation (rb) or η
resultsNo significant differences emerged in age or education. While MMSE scores were slightly lower in patients, major impairments were found in executive function, attention, and memory (all p < 0.001, FDR-corrected). Cognitive deficits were independent of mood, fatigue, and pain. Patients with complicated HSP (cHSP) showed greater impairment than those with pure HSP (pHSP). SPG4 patients exhibited specific deficits despite preserved global cognition.
conclusionCognitive impairment is a relevant but underrecognized feature in HSP. Comprehensive neuropsychological testing is critical, as global screening may miss relevant deficits.
Indexed as
Identifiers
41586951What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.